Alteration of tissue expression of human beta defensin-1 and human beta defensin-2 in psoriasis vulgaris following phototherapy

References

• Akbulak O, Karadag AS, Akdeniz N, Ozkanli S, Ozlu E, Zemheri E, Oguztuzun S (2018) Evaluation of oxidative stress via protein expression of glutathione S-transferase and cytochrome p450 (CYP450) ısoenzymes in psoriasis vulgaris patients treated with methotrexate. Cutan Ocul Toxicol 37: 180–185.
   PubMed Web of Science ®Google Scholar
• Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG (2001) Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 117:106–111
   PubMed Web of Science ®Google Scholar
• Bardan A, Nizet V, Gallo RL (2004) Antimicrobial peptides and the skin. Exp Opin Biol Ther 4: 543–549
   PubMed Web of Science ®Google Scholar
• Batycka-Baran A, Maj J, Wolf R, Szepietowski JC (2014) The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis. J Immunol Res 628289:1–10.
   Google Scholar
• Bierkarre H, Harder J, Cuthbert Ret al (2016) Differential expression of antimicrobial peptides in psoriasis and psoriatic arthritis as a novel contributory mechanism for skin and joint disease heterogeneity. Scand J Rheumatol 45:188–196.
   PubMed Web of Science ®Google Scholar
• de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J. (2005) High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopicdermatitis. J Invest Dermatol 125:1163–1173.
   PubMed Web of Science ®Google Scholar
• Fischer AH, Jacobson KA, Rose J, Zeller R. (2008) Hematoxylin and eosin staining of tissue and cell sections, C S Harb Protoc; 2008; doi:10.1101/pdb.prot4986
   Google Scholar
• Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG (1997) Expression of natural peptide antibiotics in human skin. Lancet 350:1750–1751
   PubMed Web of Science ®Google Scholar
• Gambichler T, Skrygan M, Tomi NS, Altmeyer P, Kreuter A (2006) Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy. Br J Dermatol 155: 1275–1278
   PubMed Web of Science ®Google Scholar
• Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A (2008) Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Aller Immunol 147: 17–24
   PubMed Web of Science ®Google Scholar
• Gambichler T, Kobus S, Kobus A, Tigges C, Scola N, Altmeyer P, Kreuter A, Bechara FG, Skrygan M (2011) Expression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients. Regul Pept 167: 163–166
   PubMedGoogle Scholar
• Gambichler T, Bechara FG, Scola N, Rotterdam S, Altmeyer P, Skrygan M (2012) Serum levels of antimicrobial peptides and proteins do not correlate with psoriasis severity and are increased after treatment with fumaric acid esters. Arch Dermatol Res 304: 471–474
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Jung HJ, Kim MJ, Roh NK, Jung JW, Lee YW, Choe YB, Ahn KJ (2014) Serum levels of LL- 37 and inflammatory cytokines in plaque and guttate psoriasis. Mediat Inflam 2014: 268257
   PubMed Web of Science ®Google Scholar
• Jansen PA, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jongh GJ, van Vlijmen-Willems IM, Bergboer JG, van Rossum MM, de Jong EM, den Heijer M, Evers AW, Bergers M, Armour JA, Zeeuwen PL, Schalkwijk J (2009) Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant co ncentrations in lesional skin. PLoS One 4: e4725
   PubMed Web of Science ®Google Scholar
• Kenshi Y, Richard LG (2008) Antimicrobial peptides in human skin disease. Eur J Dermatol 18: 11–21
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz M, Majewski S (2016) The role of antimicrobial peptides in chronic inflammatory skin diseases. Postepy Dermatol Alergol 33: 6–12
   PubMed Web of Science ®Google Scholar
• Morizane S, Gallo RL (2012) Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol 39: 225–230
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151–1160
   PubMed Web of Science ®Google Scholar
• Ozlu E, Karadag AS, Ozkanli S, Oguztuzun S, Akbulak O, Uzuncakmak TK, Demirkan S, Akdeniz N (2017) The investigation of antimicrobial peptides expression and its related interaction with methotrexate treatment in patients with psoriasis vulgaris. Cutan Ocul Toxicol 36: 321–326.
   PubMed Web of Science ®Google Scholar
• Schauber J, Gallo RL (2008) Antimicrobial peptides and the skin immune defense system. J Aller Clin Immunol 122: 261–266
   PubMed Web of Science ®Google Scholar
• Schauber J, Dorschner RA, Coda AB, Büchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zügel U, Bikle DD, Modlin RL, Gallo RL (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803–811
   PubMed Web of Science ®Google Scholar
• Takahashi T, Gallo RL (2017) The critical and multifunctional roles of antimicrobial peptides in dermatology. Dermatol Clin 35: 39–50
   PubMed Web of Science ®Google Scholar
• Vähävihu K, Ala-Houhala M, Peric M, Karisola P, Kautiainen H, Hasan T, Snellman E, Alenius H, Schauber J, Reunala T (2010) Narrow band ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol 163:321–328
   PubMed Web of Science ®Google Scholar